응고 검사 시장 규모, 점유율, 성장 분석 : 제품별, 검사별, 기술별, 용도별, 최종 사용자별, 지역별 - 업계 예측(2026-2033년)

Coagulation Testing Market size was valued at USD 4.26 Billion in 2024 and is poised to grow from USD 4.78 Billion in 2025 to USD 12.01 Billion by 2033, growing at a CAGR of 12.2% during the forecast period (2026-2033).

The global Coagulation Testing Market is experiencing substantial growth, driven by several influencing factors. Coagulation testing is essential for diagnosing and monitoring various medical conditions related to blood clotting, aligning with the increasing prevalence of cardiovascular diseases and blood disorders, including hemophilia and von Willebrand disease. The demand for coagulation testing is further fueled by the rising number of surgical procedures and trauma cases that require precise diagnostics. Additionally, stringent regulatory requirements for diagnostic products and devices play a crucial role in shaping the market landscape, necessitating compliance with quality standards and regulatory approvals for new market entrants. This combination of factors highlights the critical importance of coagulation testing in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coagulation Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coagulation Testing Market Segments Analysis

Global Coagulation Testing Market is segmented by Product, Test, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Consumables, Reagents And Standards, Controls and Calibrations. Based on Test, the market is segmented into Complete Blood Count (CBC), Factor V Assay, Fibrinogen Level, Prothrombin Time, Platelet Count, Thrombin Time, Bleeding Time and Others. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Others. Based on Application, the market is segmented into Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Other. Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Point-of-Care Testing and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coagulation Testing Market

The rising incidence of cardiovascular diseases, along with a worldwide aging population, highlights the escalating demand for coagulation testing as a crucial diagnostic resource. Moreover, innovations in diagnostic technology, such as optical and electrochemical coagulation testing methods, contribute to improved precision and efficiency of results. This leads to greater acceptance and implementation of these tests in various healthcare environments. The convergence of these factors not only emphasizes the importance of coagulation testing in patient management but also propels its continuous evolution to meet the growing healthcare needs. Consequently, these developments collectively drive the expansion of the coagulation testing market.

Restraints in the Coagulation Testing Market

A significant restraint within the coagulation testing market lies in the challenges related to the standardization of testing methodologies, particularly due to variations in results among different laboratories and environments. These discrepancies can create difficulties for healthcare professionals in accurately interpreting test outcomes, thereby impacting the overall reliability of coagulation testing. As a result, the inconsistency of results can hinder effective diagnosis and treatment, posing a hurdle in delivering optimal patient care and affecting the confidence of both practitioners and patients in the testing process. Addressing these standardization issues is crucial to enhance the coherence and trustworthiness of coagulation testing practices.

Market Trends of the Coagulation Testing Market

The coagulation testing market is experiencing a notable trend towards point-of-care testing, driven by the increasing demand for rapid and decentralized diagnostic solutions. This shift is primarily motivated by the necessity for swift decision-making in emergency and outpatient scenarios, where timely results can significantly impact patient outcomes. Advances in technology are enabling the development of portable, user-friendly coagulation testing devices, which are being embraced across diverse healthcare settings. As healthcare providers prioritize efficiency and patient-centric care, the adoption of these innovative testing solutions is expected to grow, reshaping the landscape of coagulation diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Coagulation Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• Reagents And Standards
• Controls
• Calibrations

Global Coagulation Testing Market Size by Test & CAGR (2026-2033)

• Market Overview
• Complete Blood Count (CBC)
• Factor V Assay
• Fibrinogen Level
• Prothrombin Time
• Platelet Count
• Thrombin Time
• Bleeding Time
• Others

Global Coagulation Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Optical Technology
• Mechanical Technology
• Electrochemical Technology
• Others

Global Coagulation Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Activated Clotting Time (ACT)
• Thrombin Time (TT)
• Partial Thromboplastin Time (PTT)
• Activated Partial Thromboplastin Time (APTT)
• Prothrombin Time (PT)
• Other

Global Coagulation Testing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinical Laboratories
• Point-of-Care Testing
• Others

Global Coagulation Testing Market Size & CAGR (2026-2033)

• North America (Product, Test, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Test, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (Werfen) (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA) (now Abbott)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyowa Medex Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maccura Biotechnology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations